GWS
TMO icon

Greykasell Wealth Strategies’s Thermo Fisher Scientific TMO Stock Holding History

Greykasell Wealth Strategies’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Sell
870
-39
-4% -$18.7K 0.16% 99
2026
Q1 		$447K Hold
909
– – 0.18% 95
2025
Q4 		$527K Buy
909
+25
+3% +$14.1K 0.21% 91
2025
Q3 		$429K Buy
884
+15
+2% +$6.98K 0.18% 95
2025
Q2 		$352K Sell
869
-315
-27% -$132K 0.17% 98
2025
Q1 		$589K Hold
1,184
– – 0.31% 76
2024
Q4 		$616K Buy
+1,184
New +$651K 0.34% 78

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Greykasell Wealth Strategies's TMO Position: Q2 2026 in Review

Greykasell Wealth Strategies reduced its Thermo Fisher Scientific (TMO) stake by 4.3% in Q2 2026, selling an estimated $18.7K and leaving 870 shares worth $436K. The position accounts for 0.16% of the portfolio, ranked #99.

Greykasell Wealth Strategies first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $616K in Q4 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Greykasell Wealth Strategies held 870 shares of Thermo Fisher Scientific worth $436K as of Q2 2026.
  • Greykasell Wealth Strategies sold 39 Thermo Fisher Scientific shares in Q2 2026, an estimated $18.7K.
  • Thermo Fisher Scientific made up 0.16% of Greykasell Wealth Strategies's portfolio in Q2 2026, its #99 holding.
  • Greykasell Wealth Strategies first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Greykasell Wealth Strategies's Thermo Fisher Scientific position peaked at $616K in Q4 2024.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2026, filed 11 Aug 2026.